179 related articles for article (PubMed ID: 22471461)
1. Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas.
Cao XL; Xu RJ; Zheng YY; Liu J; Teng YS; Li Y; Zhu J
Asian Pac J Cancer Prev; 2011; 12(12):3245-9. PubMed ID: 22471461
[TBL] [Abstract][Full Text] [Related]
2. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.
Krecicki T; Fraczek M; Jelen M; Podhorska M; Szkudlarek T; Zatonski T
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):494-7. PubMed ID: 12739032
[TBL] [Abstract][Full Text] [Related]
3. Expression of MMP-1, TIMP-1, and type I collagen in laryngeal carcinoma.
Sawatsubashi M; Mizokami H; Tokunaga O; Shin T
Mod Pathol; 1998 Sep; 11(9):878-85. PubMed ID: 9758368
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
[TBL] [Abstract][Full Text] [Related]
5. [Expression and pathobiological significance of Col I, Col IV and Fn in laryngeal squamous cell carcinomas].
Zhang H; Li W; Shang W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Dec; 23(24):1130-3. PubMed ID: 20359090
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of CD44v6 and MMP-9 in laryngeal squamous cell carcinoma].
Qin G; Li W; Sun X; Zhu L; Chen Z
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Aug; 19(15):688-91. PubMed ID: 16248506
[TBL] [Abstract][Full Text] [Related]
7. [Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Yang L; Shang X; Zhao X; Lin Y; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 26(21):989-92. PubMed ID: 23373240
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of matrix metalloproteinase-2 in laryngeal squamous cell carcinoma].
Wang X; Shan Y; Wang J; Luo S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1109-10. PubMed ID: 17357514
[TBL] [Abstract][Full Text] [Related]
9. Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer.
Krecicki T; Zalesska-Krecicka M; Jelen M; Szkudlarek T; Horobiowska M
Clin Otolaryngol Allied Sci; 2001 Dec; 26(6):469-72. PubMed ID: 11843925
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.
de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G
Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].
Zheng Y; Ding J; Wang CL; Jiao SS; Qu LM; Bahargul ; Bao H; Chen X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):299-302. PubMed ID: 21624249
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Peschos D; Damala C; Stefanou D; Tsanou E; Assimakopoulos D; Vougiouklakis T; Charalabopoulos K; Agnantis NJ
Histol Histopathol; 2006 Jun; 21(6):603-8. PubMed ID: 16528670
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of MMP-2, -9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas.
Ondruschka C; Buhtz P; Motsch C; Freigang B; Schneider-Stock R; Roessner A; Boltze C
Pathol Res Pract; 2002; 198(8):509-15. PubMed ID: 12389993
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
17. Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma.
Christopoulos TA; Papageorgakopoulou N; Ravazoula P; Mastronikolis NS; Papadas TA; Theocharis DA; Vynios DH
Oncol Rep; 2007 Oct; 18(4):855-60. PubMed ID: 17786346
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Liu WW; Zeng ZY; Wu QL; Hou JH; Chen YY
Otolaryngol Head Neck Surg; 2005 Mar; 132(3):395-400. PubMed ID: 15746850
[TBL] [Abstract][Full Text] [Related]
19. Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma.
Matulka M; Konopka A; Mroczko B; Pryczynicz A; Kemona A; Groblewska M; Sieskiewicz A; Olszewska E
Dis Markers; 2019; 2019():3136792. PubMed ID: 31143300
[TBL] [Abstract][Full Text] [Related]
20. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
